Cart
Rx 🏭 SII (Serum Institute) ❄️ Cold Chain 2–8°C 👶 Oral – 2 mL 🌐 WHO Prequalified 🇮🇳 Made in India 🛡️ G9 Strain Included
Rotasiil-Liquid Rotavirus Vaccine Live Attenuated Oral by Serum Institute of India – Box Front, 1 dose 2mL with VacciHub watermark

Rotasiil®-Liquid · SII · 1 Dose – 2 mL · Oral Administration Only · Pentavalent [G1, G2, G3, G4, G9]

Rotasiil composition – Live Attenuated Bovine-Human Reassortant G1,G2,G3,G4,G9 ≥10^5.6 FFU per serotype, grown on Vero cells, Serum Institute

Each 2 mL: Live Attenuated Bovine-Human Reassortant [G1,G2,G3,G4,G9]* ≥10⁵·⁶ FFU/serotype · *Grown on Vero cells · Serum Institute of India

Rotasiil-Liquid – Pentavalent Rotavirus Vaccine (Live Attenuated, Oral) I.P.

Full Name: Rotavirus Vaccine (Live Attenuated, Oral) I.P.
Manufacturer: Serum Institute of India Pvt. Ltd., Pune  |  Pack: 1 Dose – 2 mL Oral Liquid  |  Route: Oral Administration Only (NEVER inject)

✓ SII – World's Largest Vaccine Mfr. ❄️ Cold Chain Assured 👩‍⚕️ Certified Nurse 🌐 WHO Prequalified 🛡️ G9 Included – India-Specific
Rotasiil-Liquid is a Pentavalent Live Attenuated Oral Rotavirus Vaccine by the Serum Institute of India (SII). Each 2 mL oral dose contains 5 live attenuated Bovine-Human Reassortant rotavirus strains covering serotypes G1, G2, G3, G4 and G9 — each at ≥10⁵·⁶ FFU — grown on Vero cells. G9 is a serotype uniquely prevalent in India and South Asia, making Rotasiil especially well-suited to India's rotavirus epidemiology. A 3-dose oral series starting at 6 weeks provides strong protection against severe rotavirus gastroenteritis — the #1 cause of infant hospitalisation from diarrhoeal disease in India.
🛡️ 5 Rotavirus Serotypes Covered by Rotasiil-Liquid
G1
≥10⁵·⁶ FFU
G2
≥10⁵·⁶ FFU
G3
≥10⁵·⁶ FFU
G4
≥10⁵·⁶ FFU
G9
≥10⁵·⁶ FFU ⭐

⭐ G9: India's most prevalent circulating serotype — unique to Rotasiil among pentavalent rotavirus vaccines · FFU = Focus Forming Units · All 5 strains are Live Attenuated Bovine-Human Reassortants grown on Vero cells

🦠 Why Does My Baby Need Rotavirus Vaccine?

🌡️

Rotavirus – #1 Cause of Infant Diarrhoea

Rotavirus is the leading cause of severe diarrhoea and dehydration in children under 5 globally. Nearly every child gets infected by age 5. In India, rotavirus causes ~98,000 child deaths annually — all preventable with the 3-dose oral vaccine.

💧

Rapid, Severe Dehydration

Rotavirus triggers simultaneous watery diarrhoea AND vomiting — making oral rehydration extremely difficult. Infants can become critically dehydrated in hours, requiring IV fluids and hospital admission.

🇮🇳

G9 — India's Predominant Strain

G9 accounts for 20–30% of rotavirus disease in India and South Asia. Rotasiil uniquely includes G9 alongside the 4 globally dominant G-types — making it India's most contextually matched rotavirus vaccine.

👄

Why Oral? – Gut Immunity

Rotavirus infects the intestinal lining — an oral live vaccine directly stimulates gut-specific secretory IgA immunity at the site of infection, providing superior mucosal protection compared to any injected vaccine.

👥 Who Should Get Rotasiil-Liquid?

👶

All Healthy Infants (6–14 Weeks) ⭐

Primary target: all healthy infants starting at 6 weeks of age. IAP 2024 recommends rotavirus vaccination as routine infant immunisation. First dose must begin before 15 weeks.

🍼

Premature Infants

Preterm babies face higher risk of severe rotavirus disease. Rotasiil is given at chronological age (6 weeks), regardless of gestational age. Discuss with your paediatrician for very preterm infants.

🫀

Infants with Chronic Conditions

Congenital heart disease, chronic lung/liver conditions — all increase severity of rotavirus illness. The oral vaccine is especially important for these higher-risk groups.

🌡️

High-Risk Environments

Infants in daycare, joint families or areas with questionable water quality face higher rotavirus exposure. Early vaccination before 15 weeks ensures full protection during the highest-risk period.

🔄

Catch-Up (Within Age Window)

If Dose 1 was missed: catch up is possible up to 14 weeks 6 days. All 3 doses must be complete before 32 weeks. Call VacciHub NOW if baby is approaching these limits.

🌍

Families Preferring Indian Vaccine

Rotasiil is India's own WHO-prequalified rotavirus vaccine — manufactured by SII at an accessible price, without compromising on efficacy or safety vs imported alternatives.

🔬 Rotasiil-Liquid Composition – Per 2 mL Oral Dose

As per Serum Institute of India manufacturer label. Each 2 mL dose contains:

ComponentQuantityNotes
ACTIVE INGREDIENTS – 5 LIVE ROTAVIRUS STRAINS
Live Attenuated Bovine-Human Reassortant Rotavirus G1 ≥ 10⁵·⁶ FFU All 5 strains grown on Vero cells (WHO-approved cell line).

Bovine-Human Reassortants: human G-type outer coat proteins (the target antigen) + bovine WC3 strain inner proteins — this design induces human serotype-specific immunity while maintaining excellent safety through attenuation.
Live Attenuated Bovine-Human Reassortant Rotavirus G2≥ 10⁵·⁶ FFU
Live Attenuated Bovine-Human Reassortant Rotavirus G3≥ 10⁵·⁶ FFU
Live Attenuated Bovine-Human Reassortant Rotavirus G4≥ 10⁵·⁶ FFU
Live Attenuated Bovine-Human Reassortant Rotavirus G9≥ 10⁵·⁶ FFU
PRODUCTION & ADMINISTRATION
Cell substrateVero cellsWHO-approved mammalian cell line for vaccine production
Dose volume2 mLOral administration only — never inject
MFG. LIC. NO.10Serum Institute of India
💡 FFU = Focus Forming Units — the measure of live virus infectivity. ≥10⁵·⁶ = ≥400,000 infectious units per serotype per dose. This is the minimum potency guaranteed at release. Actual potency is typically higher, with waning accounted for through the expiry date.
⚠️ Storage: 2°C to 8°C. Do NOT freeze. Oral administration only. VacciHub nurses carry Rotasiil in validated cold boxes at 2–8°C and administer immediately on arrival.

📅 Rotasiil – IAP 2024 Oral Vaccination Schedule

DoseAgeRouteCritical Notes
⛔ AGE WINDOW: Dose 1 before 15 weeks · All 3 doses complete before 32 weeks (8 months)
Dose 1 6 weeks Oral (2 mL liquid) MUST begin before 15 weeks — not before 6 weeks
Dose 2 10 weeks Oral (2 mL liquid) Minimum 4 weeks from Dose 1
Dose 3 14 weeks Oral (2 mL liquid) All 3 doses MUST be complete before 32 weeks of age
🚨 Why are the age limits so strict? Starting too late (after 15 weeks) increases the risk of intussusception — a rare but serious bowel complication. Completing doses after 32 weeks has not been shown to be safe. These are WHO and IAP mandated limits — non-negotiable. Call VacciHub immediately if your baby is approaching 14–15 weeks without having received Dose 1.
ℹ️ Rotasiil can be co-administered on the same day as injectable vaccines (DTwP/DTaP, PCV, Hexasiil, Tetraxim) per IAP 2024. Oral first, then injections — or simultaneous at different sites. VacciHub nurses can administer multiple vaccines in one home visit.

⚙️ How Does Rotasiil Work?

1
2 mL Oral Dose Swallowed The nurse gently squirts all 2 mL of Rotasiil directly into the baby's inner cheek. The live attenuated G1–G4, G9 Bovine-Human Reassortant viruses are swallowed and reach the small intestine — the exact site where natural rotavirus infection occurs.
2
Live Virus Replicates in Intestinal Lining (Mildly) The attenuated (weakened) vaccine strains replicate mildly in intestinal epithelial cells — closely mimicking natural infection without causing disease. This direct gut replication is the key mechanism that makes oral vaccines far superior to injected vaccines for enteric infections.
3
Secretory IgA + Systemic IgG Antibodies Generated The gut immune system generates secretory IgA (sIgA) antibodies against all 5 serotypes — these coat the intestinal wall and directly neutralise rotavirus before it can infect cells. Systemic IgG antibodies are also generated. Both responses are serotype-specific (G1–G4, G9).
4
Memory Cells — Boosted with Each Dose Each of the 3 doses amplifies and broadens the immune response. After Dose 3 at 14 weeks, the baby has robust mucosal and systemic immunity against all 5 serotypes. Efficacy of ~66–80% against severe rotavirus gastroenteritis has been demonstrated in Indian Phase III trials.

⚠️ Rotasiil Side Effects

Rotasiil is a live oral vaccine — side effects reflect mild intestinal immune activation.

🟡 Common (Mild, Transient)
  • 💩 Mild temporary diarrhoea
  • 🤮 Vomiting / regurgitation
  • 😢 Irritability / fussiness
  • 🌡️ Low-grade fever
🔴 RARE — EMERGENCY — CALL DOCTOR IMMEDIATELY
  • 🚨 Intussusception (bowel obstruction)
  • 😰 Severe abdominal pain / drawing legs up
  • 🩸 Bloody or jelly-like stool
  • 😵 Persistent vomiting + extreme lethargy / paleness
🚨 Intussusception — Know the Signs: A very rare (estimated 1–2 per 100,000 vaccinated) but life-threatening bowel obstruction. Risk is highest in the 7 days after Dose 1. The strict age limits (first dose before 15 weeks) minimise this risk significantly. Go to emergency immediately if your baby shows: severe abdominal pain, drawing legs to tummy, bloody or jelly-like stool, persistent vomiting, extreme paleness or unresponsiveness. The benefit of vaccination (preventing ~1000 deaths per 100,000 infants) vastly outweighs this rare risk.
🦠 Viral shedding: Live vaccine virus may be shed in stool for 7–10 days after each dose. Practice good hand hygiene after changing diapers during this window — especially important if there are severely immunocompromised household members.

⚖️ Rotasiil-Liquid vs RotaTeq – Comparison

FeatureRotasiil-Liquid (SII)RotaTeq (MSD)
Manufacturer✓ SII, Pune, IndiaMerck (MSD), USA
G-serotypes✓ G1, G2, G3, G4, G9G1, G2, G3, G4
P-type coverageBovine P✓ P[8] (human type)
G9 (India-prevalent)✓ Yes — unique advantage✗ Not included
Dose volume2 mL oral liquid2 mL oral tube (squeeze)
Minimum FFU/serotype≥ 10⁵·⁶ FFU≥ 2.0–2.8 × 10⁶ IFU
Cell substrateVero cellsVero cells
Made in India✓ Yes – PuneNo – USA (imported)
WHO Prequalified✓ Yes✓ Yes
IAP 2024 Accepted✓ Yes✓ Yes
Schedule3 oral doses: 6, 10, 14 weeks3 oral doses: 6, 10, 14 weeks
Efficacy vs severe RV~66–80% (India trials)~74% (global trials)
ℹ️ Rotasiil's G9 advantage for India: G9 serotype causes 20–30% of rotavirus gastroenteritis cases in India. No other rotavirus vaccine marketed in India covers G9. For Indian babies, Rotasiil's G9 inclusion provides directly relevant, locally-matched protection.

🚫 Precautions & Contraindications

Do NOT give Rotasiil if:

  • History of intussusception or intestinal obstruction
  • Severe Combined Immunodeficiency (SCID) — live vaccine absolutely contraindicated
  • Baby is older than 15 weeks for Dose 1 (strict age limit)
  • Known hypersensitivity to any Rotasiil component
  • Acute severe gastroenteritis on vaccination day — defer until recovery

Use with Caution / Discuss with Paediatrician:

  • Immunocompromised infants (other than SCID) — discuss risk-benefit
  • Breastfeeding timing — some paediatricians recommend brief pause before/after oral dose
  • Severely immunocompromised household contacts — viral shedding for ~7–10 days post-dose
  • Malnutrition — may reduce oral vaccine efficacy
⚠️ ORAL ONLY — NEVER INJECT. Do NOT freeze. Must be stored at 2–8°C throughout. VacciHub nurses confirm cold chain before every dose and administer orally only.

🏥 Why Book Rotasiil with VacciHub?

👩‍⚕️

Trained in Oral Infant Vaccination

Our nurses are specifically trained in oral vaccine technique — correct cheek-directed delivery ensuring full 2 mL dose reaches the gut. 30-minute post-dose observation included.

❄️

Cold Chain – Never Frozen

Rotasiil must NEVER be frozen. Our validated cold boxes maintain exactly 2–8°C throughout every home visit. Temperature verified before each dose.

Age-Critical Dose Reminders

We track your baby's date of birth and send WhatsApp reminders to ensure Dose 1 is given before 15 weeks and all 3 doses complete before 32 weeks. Never miss the window.

100% Genuine SII Rotasiil

Sourced exclusively from authorised SII distributors. Batch numbers and expiry dates fully transparent on your WhatsApp vaccination record.

🏠

Calmer Baby at Home

Oral vaccines at home — no hospital queues, no infection risk in waiting rooms. Babies are calmer in their own surroundings, ensuring better cooperation for the oral dose.

🕐

Multi-Vaccine Home Visit

Rotasiil oral + injectable vaccines (PCV, Hexasiil) all given in the same home visit per IAP guidelines — minimising total visits while protecting your baby comprehensively.

📍 Rotasiil Home Vaccination – Cities We Cover

🏛️Delhi (All Areas)
🏙️Gurgaon
🌆Noida
🏘️Ghaziabad
🏗️Faridabad
🌇Greater Noida

Call +91 92050 04114 to confirm your area — same-day slots available.

❓ Frequently Asked Questions – Rotasiil-Liquid

Rotasiil-Liquid is a Pentavalent Rotavirus Vaccine (Live Attenuated, Oral) I.P. by Serum Institute of India. Each 2 mL oral dose contains live attenuated Bovine-Human Reassortant rotavirus strains covering G1, G2, G3, G4 and G9 — each at ≥10⁵·⁶ FFU, grown on Vero cells. G9 is uniquely prevalent in India and is not covered by RotaTeq, making Rotasiil especially well-matched to India's rotavirus burden.

Copyright © All Rights Reserved VacciHub by PSTRIDE SOLUTIONS LLP